Oryzon Genomics SA (ORYZF)
3.31
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Oryzon Genomics Cash and Short Term Investments (Quarterly) : 16.79M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.79M |
| March 31, 2026 | 25.48M |
| December 31, 2025 | 33.32M |
| September 30, 2025 | 40.46M |
| June 30, 2025 | 36.52M |
| March 31, 2025 | 4.121M |
| December 31, 2024 | 5.818M |
| September 30, 2024 | 8.415M |
| June 30, 2024 | 10.80M |
| March 31, 2024 | 11.56M |
| December 31, 2023 | 13.54M |
| September 30, 2023 | 8.812M |
| June 30, 2023 | 14.65M |
| March 31, 2023 | 20.02M |
| December 31, 2022 | 22.75M |
| September 30, 2022 | 27.22M |
| June 30, 2022 | 23.75M |
| March 31, 2022 | 28.09M |
| December 31, 2021 | |
| September 30, 2021 | 35.83M |
| June 30, 2021 | 40.00M |
| Date | Value |
|---|---|
| March 31, 2021 | 45.26M |
| December 31, 2020 | 48.46M |
| September 30, 2020 | 52.29M |
| June 30, 2020 | 55.11M |
| March 31, 2020 | 32.32M |
| December 31, 2019 | 39.57M |
| September 30, 2019 | 42.65M |
| June 30, 2019 | 28.56M |
| March 31, 2019 | 32.69M |
| December 31, 2018 | 39.23M |
| September 30, 2018 | 26.30M |
| June 30, 2018 | 31.20M |
| March 31, 2018 | 38.00M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | 33.06M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Pharma Mar SA | 193.08M |
| Grifols SA | 586.51M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alkermes Plc | 656.58M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |